The Finance and Administration Committee has been established in accordance with Section 17 (d) of the PMRA Act, No. 9 of 2019 to fulfill the following functions, among others:
(a) Assist the Authority fulfil its stewardship responsibilities by reviewing and making recommendations to the Authority on financial information, strategic financial plans and annual operations and capital budgets;

(b) Assist the Authority in fulfilling its fiduciary corporate governance and legislative responsibilities, risk management, human resources management, and asset procurement, management and disposal.

The Finance and Administration Committee meets quarterly and the current members of the Committee are as listed in the table below:

The Medicines Committee has been established in line with Section 17 of the PMRA Act, No. 9 of 2019 to, among others, perform the following functions:

 (a) advise the Authority on—

• licensing of medicines and allied substances;
• monitoring advertisement on medicines and allied substances;
• monitoring the standards relating to medicines and allied substances; and
• monitoring the conduct of clinical trials;

(b) provide technical and scientific advice on any aspect of medicines and allied substances;

(c) review risk assessment and risk management measures relating to medicines and allied substances;

(d) recommend containment measures, reporting mechanisms, remedial measures, monitoring procedures and other appropriate conditions for medicines or allied substances; and

(e) perform any other function conferred on the Medicine Committee by the Authority for purposes of this Act.

The Medicine Committee comprises experts in human medicine, veterinary medicine, pharmacology, other experts that may be deemed necessary by the Authority. The current members of the Medicines Committee are listed below:

The Medicines Safety and Quality Monitoring Technical Committee has been established in line with Section 17 of the PMRA Act, No. 9 of 2019 to advise the Authority on matters relating to medicine safety.

The Committee membership is comprised of experts in human medicine, clinical pharmacy, toxicology, pharmaceutical analysis, pathology, veterinary medicine, epidemiology, or biologicals.

The current members of the Medicines Safety and Quality Monitoring Technical Committee are listed below:

The Clinical Trial Review Committee has been established in accordance with Section 17 of the PMRA Act, No. 9 of 2019 as a Sub-Committee of the Medicines Committee to, among other functions, advise the Authority on matters related to authorization and monitoring of clinical trials.

Membership of the Clinical Trials Review Committee consists of professionals with expertise in clinical research, epidemiology, pharmacology, biostatistics, regulatory science and ethics. The Committee does co-opt to its meetings any person[s] whose knowledge or expertise of any subject under discussion is considered useful.

The current members of the Clinical Trials Review Committee are listed in the table below:

The Pharmacy Committee has been established in accordance with Section 17 of the PMRA Act, No. 9 of 2019 to, among other functions act as the disciplinary committee of the Authority.

The Committee deals with all matters relating to—

(a) the registration and discipline of pharmacists, pharmacy technologists or pharmacy assistants; and

(b) the registration, control and regulation of any pharmacy practice premises.

The current members of the Pharmacy Committee are listed below.

The Allied Substances Committee has been established in accordance with Section 17 of the PMRA Act, No. 9 of 2019 to, among other functions, provide technical and scientific advice to the Authority on matters related to regulation of allied substances.

Composition of the Allied Substances Committee consists of members with expertise in the following areas: Traditional Medicines, biopharmaceutics, medical laboratory science, biochemistry, Biomedical engineering, biological science and nursing. The Committee may co-opt to its meetings any person(s) whose knowledge or expertise of any subject under discussion is considered useful.

The Committee meets quarterly and the current members are as listed in the table below:

The Education Sub-Committee has been established in accordance with Section 17 (d) of the PMRA Act, No. 9 of 2019 to assist the Authority in dealing with all matters relating to Pharmacy education and standards in Malawi.

The Education Sub-Committee meets quarterly and the current members of the Sub-Committee are as listed in the table below:

The Medical Devices Sub-Committee has been established in accordance with Section 17 (d) of the PMRA Act, No. 9 of 2019 to advise the Authority in all matters relating to the regulation of Medical Devices.

The Medical Devices Sub-Committee meets quarterly and the current members of the Sub-Committee are as listed in the table below: